The report, Australia’s Clinical Trials Sector: Advancing innovative healthcare and powering economic growth, developed through extensive and whole-of-sector stakeholder engagement, provides a snapshot of the size and scope of Australia’s clinical trials sector. It examines how the sector is performing, highlights the significant contribution that the conduct of clinical trials makes to the Australian economy and better health outcomes, and identifies opportunities for future growth.
The report reveals that clinical trials contributed $1.4 billion to the Australian economy through direct expenditure or investment in 2019 and that the sector now employs more than 8,000 Australians. It also details that 95,000 Australians participated in clinical trials in 2019, which saw around 1,880 trials started to advance medical knowledge and provide early access to potentially life-saving new treatments or medical interventions.
Resource Documents
2021 Clinical Trials Report
